%0 Journal Article %A Shona C. Moore %A Rebekah Penrice-Randal %A Muhannad Alruwaili %A Xiaofeng Dong %A Steven T. Pullan %A Daniel P. Carter %A Kevin Bewley %A Qin Zhao %A Yani Sun %A Catherine Hartley %A En-min Zhou %A Tom Solomon %A Michael B. J. Beadsworth %A James Cruise %A Debby Bogaert %A Derrick W. Crook %A David A. Matthews %A Andrew D. Davidson %A Zana Mahmood %A Waleed Aljabr %A Julian Druce %A Richard T. Vipond %A Lisa F. P. Ng %A Laurent Renia %A Peter J. M. Openshaw %A J. Kenneth Baillie %A Miles W. Carroll %A Malcolm G. Semple %A Lance Turtle %A Julian A. Hiscox %T Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19 %D 2020 %R 10.1101/2020.03.05.20032011 %J medRxiv %P 2020.03.05.20032011 %X COVID-19 is a complex disease phenotype where the underlying microbiome could influence morbidity and mortality. Amplicon and metagenomic MinION based sequencing was used to rapidly (within 8 hours) identify SARS-CoV-2 and assess the microbiome in nasopharyngeal swabs obtained from patients with COVID-19 by the ISARIC 4C consortium.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://isaric.tghn.org Funding StatementThis work was supported by the United States Food and Drug Administration grant number HHSF223201510104C ‘Ebola Virus Disease: correlates of protection, determinants of outcome and clinical management’ amended to incorporate urgent COVID-19 studies. Awarded to J.A.H., A.D., D.A.M. and M.W.C. Recruitment, sample acquisition, transport, laboratory and management costs were supported by the Medical Research Council “Protocol for Severe Emerging Infection” grant number MC_PC_19025 awarded to J.K.B., M.G.S., and P.J.M.O. This work was supported by Research Center, King Fahad Medical City, Saudi Arabia grant number 019-003 ‘Elucidating the viral biology of MERS-CoV and the host response using high resolution sequencing’. Awarded to W.A. This work was supported by the Medical Research Council Discovery Medicine North Doctoral Training Partnership and directly funds the studentship of R.P.-R. This work was supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. Awarded to T.S. L.T. is a Wellcome Trust clinical career development fellow, supported by grant number 205228/Z/16/Z. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be obtained from the corresponding author by request %U https://www.medrxiv.org/content/medrxiv/early/2020/03/08/2020.03.05.20032011.full.pdf